A Pilot Study of Haloperidol Treatment of Psychosis and Behavioral Disturbance in Alzheimer's Disease
Arch Neurol 46:854-857, Devanand,D.P.,et al, 1989
Clinical and Pathological Aspects of Parkinsonism in Alzheimer's Disease, A Role for Extranigral Factors?
Arch Neurol 46:651-657, Morris,J.C.,et al, 1989
Apraxia in Alzheimer's Disease
Neurol 39:664-668, Rapcsak,S.Z.,et al, 1989
Tetrahydroaminoacridine (THA) in Alzheimer's Disease, Not Ready for Routine Use
BMJ 298:845-846, Graham,T.R.&Lewis,C.T., 1989
Clonidine Treatment of Alzheimer's Disease
Arch Neurol 46:376-378, Mohr,E.,et al, 1989
Amyloid A4 Protein and Its Precursor in Down's Syndrome and Alzheimer's Disease
NEJM 320:1446-1452, 1484-14861989., Rumble,B.,et al, 1989
Relationship of Hearing Impairment to Dementia and Cognitive Dysfunction in Older Adults
JAMA 261:1916-1919, Uhlmann,R.F.,et al, 1989
Quantitation of Cerebral Atrophy in Preclinical and End-Stage Alzheimer's Disease
Ann Neurol 25:450-459, delaMonte,S.M., 1989
Diagnosis of Dementia:Clinicopathologic Correlations
Neurol 39:76-79, Boller,F.,et al, 1989
Cortical Lewy Body Dementia:Clinical Features and Classification
JNNP 52:185-192, Gibb,W.R.G.,et al, 1989
Prevalence of Alzheimer's Disease in a Community Population of Older Persons
JAMA 262:2551-2556, 2591-25921989., Evans,D.A.,et al, 1989
Neuropathological Correlates of Leuko-araiosis
Arch Neurol 46:1124-1128, Janota,I.,et al, 1989
Gerstmann-Straussler-Scheinker Disease, I, Extending the Clinical Spectrum
Neurol 39:1446-1452, Farlow,M.R.,et al, 1989
Gerstmann-Straussler-Scheinker Disease, II, Neurofibrillary Tangles & Plaques with PrP-amyloid in an Affected Family
Neurol 39:1453-1461, Ghetti,B.,et al, 1989
Effects of a Training Programme to Reduce Stress in Carers of Patients with Dementia
BMJ 299:1375-1379, Brodaty,H.&Gresham,M., 1989
Predisposing Locus for Alzheimer's Disease on Chromosome 21
Lancet 1:352-355, Goate,A.M.,et al, 1989
Geographical Relation Between Alzheimer's Disease and Aluminium in Drinking Water
Lancet 1:59-62, Martyn,C.N.,et al, 1989
Long-Term Administration of Oral Physostigmine in Alzheimer's Disease
Neurol 38:1837-1841, Stern,Y.,et al, 1988
Aluminium, Chemical Physiology and Alzheimer's Disease
Lancet 2:1008-1010, Birchall,J.D.&Chappell,J.S., 1988
Dystonia and Tremor Induced by Peripheral Trauma:Predisposing Factors
JNNP 51:1512-1519, Jankovic,J.&VanDer Linden,C., 1988
Familial Alzheimer's Disease with Myoclonus and'Spongy Change'
Arch Neurol 45:1097-1100, Duffy,P.,et al, 1988
Olfactory Dysfunction in Parkinsonism:A General Deficit Unrelated to Neurologic Signs, Disease Stage, or Duration
Neurol 38:1237-1244, Doty,R.L.,et al, 1988
Vascular Dementia and Dementia of the Alzheimer Type, Cognition, Ventricular Size & Leuko-Araiosis
Arch Neurol 45:719-721, Aharon-Peretz,J.,et al, 1988
Aphasia in Senile Dementia of the Alzheimer Type
Ann Neurol 23:365-370, Faber-Langendoen,K.,et al, 1988
Dementia in Down's Syndrome:Cerebral Glucose Utilization, Neuropsychological Assessment, and Neuropathology
Neurol 38:938-942, Schapiro,M.B.,et al, 1988
Risk of Dementia in Relatives of Patient with Alzheimer's Disease
Neurol 38:786-790, Huff,F.J.,et al, 1988
Clinically Diagnosed Alzheimer's Disease:Autopsy Results in 150 Cases
Ann Neurol 24:50-56, Joachim,C.L.,et al, 1988
Normal Ageing, Impaired Cognitive Function, & Senile Dementia of the Alzheimer's Type:A Continuum
Lancet 1:1265-1267, Brayne,C.&Calloway,P., 1988
Alzheimer Disease:Clinical and Biological Heterogeneity
Ann Int Med 15:298-311, Friedland,R.P.,et al, 1988
Olfactory Detection & Identification Performance are Dissociated in Early Alzheimer's Disease
Neurol 38:1228-1232, Koss,E.,et al, 1988
Intraventricular Bethanechol Infusion for Alzheimer's Disease:Double-Blind & Escalating-Dose Trials
Neurol 38:219-222, 307-3081988., Penn,R.D.,et al, 1988
Early Alzheimer's Disease, Diagnostic Considerations
Arch Neurol 45:345-349, Morris,J.C.&Fulling,K., 1988
The NINCDS-ADRDA Work Group Criteria for the Clin Diag of Prob Alzheimer's Dis:A Clinicopath Study of 57 Cases
Neurol 38:359-364, Tierney,M.D.,et al, 1988
Clinical, Path, & Neurochem Changes in Dementia:Subgroup with Preserved Mental Status & Neocortical Plaques
Ann Neurol 23:138-144, Katzman,R.,et al, 1988
Motor Vehicle Crashes in Dementia of the Alzheimer Type
Ann Neurol 24:782-786, Friedland,R.P.,et al, 1988
Who May Drive? Who May Not? Who Shall Decide?
Ann Neurol 24:787-788, Drachman,D.A., 1988
Neurologic Fragments. I. Clinical Observations in Demented Patients
Neurol 38:1868-1873, Fisher,C.M., 1988
Immunocytochemistry of Neurofibrillary Tangles in Dementia Pugilistica and Alzheimer's Disease:Evidence for Common Genesis
Lancet 2:1456-1458, Roberts,G.W., 1988
Clinico-Pathologic Studies in Dementia:Nondemented Subjects with Pathologically Confirmed Alzheimer's Disease
Neurol 38:1682-1687, Crystal,H.,et al, 1988
Diagnosing Dementia:Do We Get It Right?
BMJ 297:894-896, Homer,A.C.,et al, 1988
Brain Amyloid and Alzheimer Disease
Ann Int Med 109:41-54, Vinters,H.V.,et al, 1988
The Molecular Genetic Revolution, Its Impact on Clinical Neurology
Arch Neurol 45:1366-1376, Payne,C.S.&Roses,A.D., 1988
Diffuse Lewy Body Disease and Progressive Dementia
Neurol 38:1520-1528, Burkhardt,C.R.,et al, 1988
Why Are Alzheimer Patients Thin?
Age & Ageing 17:21-28988., Singh,S.,et al, 1988
The Psychiatric Symptoms of Alzheimer's Disease
J Am Geriatr Soc 36:7-12, Merriam,A.E.,et al, 1988
Rate of Ventricular Enlargement in Dementia of Alzheimer Type Correl with Rate of Neuropsychological Deterioration
Neurol 37:1135-1140, Luxenberg,J.S.,et al, 1987
Cortical Biopsy Results in Alzheimer's Disease:Correlation with Cognitive Deficits
Neurol 37:1201-1204, Martin,E.M.,et al, 1987
Predictors of Disease Course in Patients with Probable Alzheimer's Disease
Neurol 37:1649-1653, Stern,Y.,et al, 1987
Risk Factors for Alzheimer's Disease:A Case-Control Study
Neurol 37:1630-1633, Shalat,S.T.,et al, 1987
The Neurologic Examination in Patients with Probable Alzheimer's Disease
Arch Neurol 44:929-932, Huff,F.J.,et al, 1987